A Multicenter, Study of the Safety and Pharmacokinetics of Intravenously Infused Berubicin in Pediatric Patients With Progressive, Refractory, or Recurrent High Grade Gliomas
- First Posted Date
- 2021-10-19
- Last Posted Date
- 2024-06-06
- Lead Sponsor
- WPD Pharmaceuticals Sp. z o.o.
- Registration Number
- NCT05082493
Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme (WHO Grade IV)
Phase 1
Terminated
- Conditions
- Recurrent Glioblastoma Multiforme
- Interventions
- First Posted Date
- 2021-06-07
- Last Posted Date
- 2024-06-06
- Lead Sponsor
- WPD Pharmaceuticals Sp. z o.o.
- Target Recruit Count
- 5
- Registration Number
- NCT04915404
- Locations
- 🇵🇱
Uniwersyteckie Centrum Kliniczne Klinika Onkoligii i Radioterapii, Gdańsk, Poland
🇵🇱Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie,Państwowy Instytut Badawczy w Warszawie,Klinika Nowotworów Głowy i Szyi, Warszawa, Poland
© Copyright 2025. All Rights Reserved by MedPath